Log in to save to my catalogue

Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients wit...

Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients wit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2974001045

Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open‐labeled randomized control trial

About this item

Full title

Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open‐labeled randomized control trial

Publisher

England: John Wiley & Sons, Inc

Journal title

CNS neuroscience & therapeutics, 2024-03, Vol.30 (3), p.e14650-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aims
To explore the pharmacological treatment of vascular depression (VaDep) and whether the blood levels of neurotransmitters can reflect the VaDep severity.
Methods
VaDep patients with somatic symptoms were enrolled and randomly received venlafaxine + tandospirone (Combined Group) or venlafaxine (Monotherapy Group). The treatment efficac...

Alternative Titles

Full title

Efficacy and safety of venlafaxine hydrochloride combined with tandospirone citrate for patients with vascular depression accompanied by somatic symptoms: An open‐labeled randomized control trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2974001045

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2974001045

Other Identifiers

ISSN

1755-5930,1755-5949

E-ISSN

1755-5949

DOI

10.1111/cns.14650

How to access this item